skip to primary navigationskip to content
 

CIN News

Site News

2016 EUROPEAN PATENT OFFICE INVENTOR AWARD

Helen Lee (Haematology) was selected from 470 nominations by the European Patent Office to be one of the 3 finalists for SAMBA, the technology she and her group have developed. They have greatly simplified the detection of infectious diseases by nucleic acid amplification suitable for resource-poor settings.

2016 EUROPEAN PATENT OFFICE INVENTOR AWARD - Read More…

Immunotherapy - Cancer cure?

The researchers genetically modified the t-cells to engineer a new targeting mechanism - chimeric antigen receptors - to target acute lymphoblastic leukaemia.

Immunotherapy - Cancer cure? - Read More…

Patrick Sissons Evelyn Trust Research Fellowship in Infection and Immunity

In memory of Professor Sir Patrick Sissons MD, FRCP, FRCPath, FMedSci. (1945-2016), Darwin College is seeking to elect a stipendiary Research Fellow. Patrick Sissons was the leader of the University of Cambridge’s Clinical School as Regius Professor of Physic (2005–2012) following his service as Head of the Department of Medicine (1993-2005).

Patrick Sissons Evelyn Trust Research Fellowship in Infection and Immunity - Read More…

The Borysiewicz Biomedical Sciences Fellowship Programme

Application deadline: 17:00 on Monday 26 February 2018. The Borysiewicz Biomedical Sciences Fellowships have been developed in honour of Sir Leszek Borysiewicz, a pioneer in the biomedical sciences, who when Vice-Chancellor of the University led and shaped the development of key provisions for Cambridge’s postdoc community.

The Borysiewicz Biomedical Sciences Fellowship Programme - Read More…

Computer-designed antibodies target toxins associated with Alzheimer’s disease

Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production.

Computer-designed antibodies target toxins associated with Alzheimer’s disease - Read More…

Huge £114million research investment announced for Cambridge- BRC

Cambridge is set to get a huge £114m from the Government to make world-first medical breakthroughs, as part of a record package of research funding announced today by Health Secretary Jeremy Hunt.

Huge £114million research investment announced for Cambridge- BRC - Read More…

60 YEARS OF THE BRITISH SOCIETY FOR IMMUNOLOGY

The British Society for Immunology celebrates 60 years on Tuesday 11 October. We are proud to have supported immunology and immunologists during this time and we hope as many of you as possible are able to join us in celebrating this important milestone.

60 YEARS OF THE BRITISH SOCIETY FOR IMMUNOLOGY - Read More…

Cancer Research UK - Immunology call

At Cancer Research UK we recognise that immunology has underpinned some of the most exciting discoveries in modern cancer research. We are committed to supporting cutting-edge immunology to deepen our understanding of the interactions between the immune system and tumours.

Cancer Research UK - Immunology call - Read More…

Case study on Department of Veterinary Medicine research informing WHO guidelines

Dr Caroline Trotter and her team at Cambridge’s Department of Veterinary Medicine have used mathematical modelling to help ensure that World Health Organisation guidelines provide the most robust and effective approach to meningitis vaccinations in Sub-Saharan Africa.

Case study on Department of Veterinary Medicine research informing WHO guidelines - Read More…

Call for EMI collaborative research projects with AstraZeneca/MedImmune

The Experimental Medicine Training Initiative (EMI) is an exciting scheme recently set up between University of Cambridge, Cambridge University Hospitals NHS Trust, NIHR Cambridge Biomedical Research Centre, and Pharmaceutical Industry partners interested in developing scientific expertise in the field of experimental medicine (Clinical Trials).

Call for EMI collaborative research projects with AstraZeneca/MedImmune - Read More…

Call for collaborative research proposals with GlaxoSmithKline

The University of Cambridge/ CUH/ GSK Joint Steering Committee (JSC) are pleased to announce a new call for collaborative Cambridge/GSK research proposals. This is the fourth annual call under the “Varsity” initiative which has to date funded 12 new collaborative medicine-focused projects. More information about the initiative can be found here.

Call for collaborative research proposals with GlaxoSmithKline - Read More…

GSK Discovery Partnership with Academia Fast Track Golden Triangle Challenge - call open External Call for proposals

This new Call for Proposals has a closing date of 28th October 2016. Key Questions that need to be considered before applying are: 1) Do you have a clear therapeutic hypothesis? 2) Do you have a defined drug target? 3) Do you have enabling expertise?

GSK Discovery Partnership with Academia Fast Track Golden Triangle Challenge - call open External Call for proposals - Read More…

The bug hunters and the microbiome

Trevor Lawley and Gordon Dougan are bug hunters, albeit not the conventional kind. The bugs they collect are invisible to the naked eye. And even though we’re teeming with them, researchers are only beginning to discover how they keep us healthy – and how we could use these bugs as drugs.

The bug hunters and the microbiome - Read More…

Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute

Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute

Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute, has received funding from Cambridge Innovation Capital (CIC) and IP Group to use the latest discoveries in the characterisation of our bacteria and their role in health and disease to develop bacteriotherapy - a radical way to treat disease based on using the bacteria themselves.

Microbiotica, the latest spin-out from the Wellcome Trust Sanger Institute - Read More…

Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its developmental pathway

Yong Yu, Jason C.H. Tsang, Cui Wang, Simon Clare, Juexuan Wang, Xi Chen, Cordelia Brandt, Leanne Kane, Lia S. Campos, Liming Lu, Gabrielle T. Belz, Andrew N. J. McKenzie, Sarah A. Teichmann, Gordon Dougan & Pentao Liu

Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its developmental pathway - Read More…

Professor Lalita Ramakrishnan elected Fellow of The Royal Society

Professor Lalita Ramakrishnan elected Fellow of The Royal Society

Lalita Ramakrishnan is the Professor of Immunology and Infectious Diseases in the Department of Medicine, University of Cambridge and has been elected Fellow of the Royal Society (2018). She studies tuberculosis disease pathogenesis in the zebrafish. The zebrafish is genetically tractable and optically transparent enabling the manipulation and monitoring of infection in real-time. The use of the zebrafish has led to surprising discoveries about TB that have immediate clinical implications.

Professor Lalita Ramakrishnan elected Fellow of The Royal Society - Read More…

Lalita Ramakrishnan elected to the U.S. National Academy of Sciences .

Professor Lalita Ramakrishnan announced as one of 84 new members of the U.S. National Academy of Sciences.

Lalita Ramakrishnan elected to the U.S. National Academy of Sciences . - Read More…

Andres Floto et al repurpose anticonvulsants as tuberculosis drug

Functional drug screening reveals anticonvulsants as enhancers of mTOR‐independent autophagic killing of Mycobacterium tuberculosis through inositol depletion

Andres Floto et al repurpose anticonvulsants as tuberculosis drug - Read More…

Sharon Peacock has been awarded a CBE

Professor Sharon Peacock has been awarded a CBE for her services to Medical Microbiology

Sharon Peacock has been awarded a CBE - Read More…

The curious relationship between diseases and immune systems

A researcher based at the Medical Research Council Human Nutrition Research Unit in the UK is improving understanding of the immune system. His work on protein interactions and how they correlate with infectious disease and inflammatory conditions could soon help to control and treat diseases

The curious relationship between diseases and immune systems - Read More…

Typhoid outbreak: genetic cause of extensive drug resistance found

The results suggest that treatment options for typhoid treatment are running out and preventative strategies are needed. “We have used genetic sequencing to uncover how this particular strain of typhoid became resistant to several key antibiotics. Sporadic cases of typhoid with these levels of antimicrobial resistance have been seen before, but this is the first time we’ve seen an ongoing outbreak – which is concerning.” Professor Gordon Dougan, a senior author from the Wellcome Sanger Institute and University of Cambridge Department of Medicine

Typhoid outbreak: genetic cause of extensive drug resistance found - Read More…

Wellcome Trust award to study link between immune system and brain disorders

A Wellcome Strategic Award of £5 million includes is granted to a consortium of seven Universities including Cambridge and two companies.

Wellcome Trust award to study link between immune system and brain disorders - Read More…

Upcoming events

The 19th Cambridge Immunology Forum – ‘Cancer Immunology’

Sep 20, 2018

Queens' College Cambridge.

Upcoming events

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2018.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more